Page last updated: 2024-10-21

tacrine and Cognitive Decline

tacrine has been researched along with Cognitive Decline in 3 studies

Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Li, Q1
Chen, Y2
Xing, S1
Liao, Q1
Xiong, B1
Wang, Y1
Lu, W1
He, S1
Feng, F1
Liu, W1
Sun, H1
Bi, A1
An, W1
Wang, C2
Hua, Y1
Fang, F1
Dong, X1
Chen, R1
Zhang, Z1
Luo, L1
Chen, H1
Xiang, S1
Huang, L1
Lin, J1
Hu, S1
Mak, SH1
Wang, Q1
Cui, W1
Han, Y1

Other Studies

3 other studies available for tacrine and Cognitive Decline

ArticleYear
Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection.
    Journal of medicinal chemistry, 2021, 05-27, Volume: 64, Issue:10

    Topics: Amyloid beta-Peptides; Animals; Binding Sites; Butyrylcholinesterase; Cell Survival; Cholinesterase

2021
SCR-1693 inhibits tau phosphorylation and improves insulin resistance associated cognitive deficits.
    Neuropharmacology, 2020, 05-15, Volume: 168

    Topics: Animals; Cell Line, Tumor; Cognitive Dysfunction; Dose-Response Relationship, Drug; Insulin Resistan

2020
Tacrine(10)-hupyridone, a dual-binding acetylcholinesterase inhibitor, potently attenuates scopolamine-induced impairments of cognition in mice.
    Metabolic brain disease, 2018, Volume: 33, Issue:4

    Topics: Animals; Behavior, Animal; Cholinesterase Inhibitors; Cognitive Dysfunction; Disease Models, Animal;

2018